These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26183184)

  • 21. Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium.
    Cattoir V; Isnard C; Cosquer T; Odhiambo A; Bucquet F; Guérin F; Giard JC
    Antimicrob Agents Chemother; 2015 Jan; 59(1):239-44. PubMed ID: 25348531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital.
    Zhong X; Xu H; Chen D; Zhou H; Hu X; Cheng G
    PLoS One; 2014; 9(12):e115185. PubMed ID: 25503276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides.
    Carsenti-Dellamonica H; Galimand M; Vandenbos F; Pradier C; Roger PM; Dunais B; Sabah M; Mancini G; Dellamonica P
    J Antimicrob Chemother; 2005 Oct; 56(4):633-42. PubMed ID: 16135525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization of an alternative mode of tigecycline binding to the bacterial ribosome.
    Schedlbauer A; Kaminishi T; Ochoa-Lizarralde B; Dhimole N; Zhou S; López-Alonso JP; Connell SR; Fucini P
    Antimicrob Agents Chemother; 2015 May; 59(5):2849-54. PubMed ID: 25753625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairing methylations at ribosome RNA, a point mutation-dependent strategy for aminoglycoside resistance: the rsmG case.
    Benítez-Páez A; Cárdenas-Brito S; Corredor M; Villarroya M; Armengod ME
    Biomedica; 2014 Apr; 34 Suppl 1():41-9. PubMed ID: 24968035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of the ramRA locus in clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline.
    Campos CB; Aepfelbacher M; Hentschke M
    New Microbiol; 2017 Apr; 40(2):135-138. PubMed ID: 28368073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular evolution of rifampicin resistance in Streptococcus pneumoniae.
    Enright M; Zawadski P; Pickerill P; Dowson CG
    Microb Drug Resist; 1998; 4(1):65-70. PubMed ID: 9533728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional, biophysical, and structural bases for antibacterial activity of tigecycline.
    Olson MW; Ruzin A; Feyfant E; Rush TS; O'Connell J; Bradford PA
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2156-66. PubMed ID: 16723578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.
    Dowzicky MJ; Chmelařová E
    Int J Antimicrob Agents; 2011 Jun; 37(6):562-6. PubMed ID: 21497066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey.
    Gonullu N; Catal F; Kucukbasmaci O; Ozdemir S; Torun MM; Berkiten R
    Chemotherapy; 2009; 55(3):161-7. PubMed ID: 19390189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome.
    Hornsey M; Ellington MJ; Doumith M; Hudson S; Livermore DM; Woodford N
    J Antimicrob Chemother; 2010 Mar; 65(3):479-82. PubMed ID: 20051474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae.
    Sung CK; Li H; Claverys JP; Morrison DA
    Appl Environ Microbiol; 2001 Nov; 67(11):5190-6. PubMed ID: 11679344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae.
    Ruzin A; Visalli MA; Keeney D; Bradford PA
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1017-22. PubMed ID: 15728897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae.
    Widdowson CA; Klugman KP
    Semin Respir Infect; 1999 Sep; 14(3):255-68. PubMed ID: 10501313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007.
    Garrison MW; Mutters R; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):288-99. PubMed ID: 19733459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2004 and 2008 as part of the Tigecycline Evaluation and Surveillance Trial.
    Darabi A; Hocquet D; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2010 May; 67(1):78-86. PubMed ID: 20385351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tigecycline.
    Pankey GA
    J Antimicrob Chemother; 2005 Sep; 56(3):470-80. PubMed ID: 16040625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints.
    Papaparaskevas J; Tzouvelekis LS; Tsakris A; Pittaras TE; Legakis NJ;
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):187-94. PubMed ID: 19836184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.